» Articles » PMID: 37928477

Prevalence of and Prognosis for Poor Immunological Recovery by Virally Suppressed and Aged HIV-infected Patients

Overview
Specialty General Medicine
Date 2023 Nov 6
PMID 37928477
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Antiretroviral therapy (ART) prolongs lifespan and decreases mortality of HIV infected patients. However, many patients do not achieve optimal immune reconstitution. The influence of non-optimal immune recovery on non-AIDS related diseases is not well defined in aged HIV-infected patients receiving ART.

Methods: A retrospective study was conducted at Tianjin Second People's Hospital, China to evaluate the association of an inadequate immunological response and non-AIDS diseases in HIV infected patients ≥60 years of age and virally suppressed for at least 2 years by ART.

Results: The study included patients ( = 666) who initiated ART between August 2009 and December 2020. The prevalence of patients with an inadequate immunological response was 29.6%. The percentage of non-AIDS diseases such as hypertension, cardiovascular disease (CVD), diabetes, tumor, and chronic kidney disease (CKD) was 32.9, 9.9, 31, 4.1, and 13%, respectively. In addition to baseline CD4+ T cell counts, CVD and tumor were associated with poor immune reconstitution in aged Chinese HIV-1 infected patients. The adjusted odds ratios (95% confidence interval) were AOR 2.45 (95% CI: 1.22-4.93) and 3.06 (95% CI: 1.09-8.56,  = 0.03). Inadequate immunological response was associated with greater mortality (AOR: 2.83, 95% CI: 1.42-5.67,  = 0.003) in this cohort.

Conclusion: These results tend to demonstrate appropriate drug selection at ART initiation and prevention of non-AIDS complications during ART decreased mortality of and an inadequate immunological response in aged HIV infected patients.

Citing Articles

P-selectin glycoprotein ligand-1 and cardiovascular diseases: from a general perspective to an HIV infection context.

Zaongo S, Song Y, Chen Y Front Cardiovasc Med. 2025; 12:1521158.

PMID: 40041169 PMC: 11876174. DOI: 10.3389/fcvm.2025.1521158.


Mechanisms of HIV-immunologic non-responses and research trends based on gut microbiota.

Sun X, Xie Z, Wu Z, Song M, Zhang Y, Zhang Z Front Immunol. 2025; 15():1378431.

PMID: 39802299 PMC: 11718445. DOI: 10.3389/fimmu.2024.1378431.


Limited restoration of T cell subset distribution and immune function in older people living with HIV-1 receiving HAART.

Li N, Zheng H, Li W, He X, Zhang M, Li X Immun Ageing. 2025; 22(1):3.

PMID: 39780181 PMC: 11708165. DOI: 10.1186/s12979-024-00497-2.


Evaluation of the effects of Artemisia Annua L. and Moringa Oleifera Lam. on CD4 count and viral load among PLWH on ART at Mbarara Regional Referral Hospital: a double-blind randomized controlled clinical trial.

Twinomujuni S, Atukunda E, Mukonzo J, Nicholas M, Roelofsen F, Ogwang P AIDS Res Ther. 2024; 21(1):22.

PMID: 38627722 PMC: 11020329. DOI: 10.1186/s12981-024-00609-4.

References
1.
Girometti N, Lander F, Mcowan A, Nwokolo N, Boffito M, Whitlock G . Rapid ART start in early HIV infection: Time to viral load suppression and retention in care in a London cohort. HIV Med. 2020; 21(9):613-615. DOI: 10.1111/hiv.12900. View

2.
Veil R, Poizot-Martin I, Reynes J, Goujard C, Seng R, Delobel P . Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infection. AIDS. 2019; 34(4):493-500. DOI: 10.1097/QAD.0000000000002447. View

3.
Manrique L, Aziz M, Adeyemi O . Successful immunologic and virologic outcomes in elderly HIV-infected patients. J Acquir Immune Defic Syndr. 2010; 54(3):332-3. DOI: 10.1097/QAI.0b013e3181d2eef1. View

4.
Ahn M, Jiamsakul A, Khusuwan S, Khol V, Pham T, Chaiwarith R . The influence of age-associated comorbidities on responses to combination antiretroviral therapy in older people living with HIV. J Int AIDS Soc. 2019; 22(2):e25228. PMC: 6389354. DOI: 10.1002/jia2.25228. View

5.
Carvalho-Silva W, Andrade-Santos J, Souto F, Coelho A, Crovella S, Guimaraes R . Immunological recovery failure in cART-treated HIV-positive patients is associated with reduced thymic output and RTE CD4+ T cell death by pyroptosis. J Leukoc Biol. 2019; 107(1):85-94. DOI: 10.1002/JLB.4A0919-235R. View